Case Report
Moraxella osolensis is an aerobic, oxidase-positive, Gram-negative coccobacillus, and has been isolated widely from environments, including hospital settings and also it is thought to be commensal of human upper respiratory tract (1) . It is not known well as human pathogen unlike M. catarrhalis.
We have experienced a pediatric case of bacteremia and possible cholecystitis due to M.osloensis.
The patient was 9 year-old boy, who had been hospitalized for long-term because of cerebral palsy due to severe birth asphyxia and hypoxic ischemic encephalopathy. He had had tracheostomy and been mechanically ventilated since his infancy. He had been dependent on parenteral nutrition via central venous catheter for years, having many catheter related blood stream infections.
Eventually, enteral nutrition via nasogastric tube was re-established, therefore central line had been removed when he was 9 years and 5 months. When his condition was stable, he had been able to spend at home for several days to weeks between hospitalizations.
Past infectious disease history included multiple urinary tract infections, blood stream infections ( due to S.aureus, Bacillus species, C.parapsilosis, etc.), and cholecystitis/cholangitis due to cholelithiasis.
One month after the removal of the central venous catheter, the patient had developed low grade fever, tachycardia with cool extremities (or, hypoperfusion).
He was admitted to Nagano Children's Hospital, and his urine and blood were sent for cultures, and intravenous cefmetazole was started initially, under the suspicion of urinary tract infection. Blood culture had yielded Moraxella osloensis.
Urine culture yielded Serratia marcescens, but it was regarded as contamination.
Culture of tracheal aspiration did not yield Moraxella species and Serratia marcescens. The antimicrobial susceptibility of M.osloensis to cefmetazole was excellent (susceptibilities to antimicrobial agents are shown in Table) , therefore the antimicrobial had been continued for 10 days.
Laboratory data on admission were as follows: white blood cells 13860/µl, with 86% of neutrophils and 8% of lymphocytes, hemoglobin 15.0g/dl, platelets 17*10 4 /mm, ALT 156IU/l, G-GTP 870IU/l, total bilirubin 3.4mg/dl, direct bilirubin 2.7mg/dl (serum levels of bilirubin and liver enzymes had significantly increased from previous values), blood glucose 101mg/dl, CRP 9.1mg/dl.
Abdominal ultrasonography revealed multiple cholelithiasis and wall thickening
A c c e p t e d M a n u s c r i p t of gall bladder, which were compatible of cholecystitis. Infection was treated successfully and the patient had recovered to the previous level of his physical status. We did not perform endoscopic retrograde cholangio-pancreatography (ERCP) or bile fluid culture, because the patient could not endure these invasive procedures.
One set of blood culture was obtained and at 48 h after collection, one aerobic blood culture bottle was positive using the BACTEC FX system (Nippon Beckton
Dickinson, Tokyo, Japan), yielding a Gram-negative small rod on Gram stain.
The Gram-negative organism was subcultured to blood agar, chocolate agar and Drigalski agar (all Nippon Beckton Dickinson, Tokyo, Japan), all results were positive for bacterial growth, and was identified as Moraxella species using ID test HN-20 (Nissui Pharmaceutical, Tokyo, Japan).
The isolate was asaccharolytic, oxidase positive, catalase positive and indole negative. The bacterial growth on 0% NaCl nutrient broth was positive.
To obtain a definitive identification of the organism, 16S rRNA gene sequencing was performed. The 16S rRNA gene fragments were amplified by standard methods. The coding 16S rRNA region of 1387 bp was directly sequenced as described elsewhere (2) A c c e p t e d M a n u s c r i p t
